Status | Study |
Terminated |
Study Name: A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) Condition: Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma Date: 2014-09-22 Interventions: Drug: pegcrisantaspase |
Recruiting |
Study Name: Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma Condition: Acute Lymphocytic Leukemia Adult Lymphoblastic Lymphoma Date: 2014-01-21 Interventions: Drug: DNR Daunorubicin 60 mg/m |
Terminated |
Study Name: Hyper-CVAD Treatment in Lymphoblastic Lymphoma Condition: Lymphoblastic Lymphoma Date: 2013-03-13 |
Completed |
Study Name: A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy Condition: Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma Date: 2012-06-25 Interventions: Drug: asparaginase Erwinia chrysanthemi |
Active, not recruiting |
Study Name: SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Condition: Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma Date: 2012-04-05 Interventions: Drug: SC-PEG 11 doses Intraven |
Completed |
Study Name: Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study Condition: Acute Lymphoblastic Leukemia Childhood Lymphoblastic Lymphoma Date: 2012-01-31 |
Terminated |
Study Name: NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma Condition: Lymphoblastic Lymphoma Date: 2011-08-17 Interventions: Drug: Prednisone Given orally |
Active, not recruiting |
Study Name: Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Condition: Lymphoblastic Leukemia, Acute T-cell Precursor T-Cell Lymphoblastic Ly Date: 2011-04-22 Interventions: Drug: BMS-906024 Other Name: N |
Recruiting |
Study Name: Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Condition: Adult B Lymphoblastic Lymphoma Childhood B Acute Lymphoblastic Date: 2010-08-27 Interventions: Drug: Cyclophosphamide Given I |
Recruiting |
Study Name: Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological Parameters Condition: Lymphoblastic Lymphoma Date: 2009-04-15 Interventions: Other: Latest generation chemotherapies for T-LBL + transplant |